Internship
Confirmed live in the last 24 hours
Incubates technology-led companies for healthcare and security
$40Hourly
No H1B Sponsorship
Vienna, VA, USA
The job is hybrid, indicating that some in-office presence is required.
US Top Secret Clearance Required
You match the following Red Cell Partners's candidate preferences
Employers are more likely to interview you if you match these preferences:
Red Cell Partners focuses on creating and supporting technology-driven companies that aim to improve healthcare and national security. Their approach involves incubating businesses that can quickly grow and adapt to market needs. The products developed by Red Cell Partners are designed to tackle significant challenges faced by the nation, utilizing advanced technology to create effective solutions. What sets Red Cell apart from other firms is their commitment to addressing critical issues through innovation and their strong sense of responsibility towards societal needs. The ultimate goal of Red Cell Partners is to develop impactful tools and solutions that contribute to the safety and well-being of the nation.
Company Size
11-50
Company Stage
N/A
Total Funding
$349.8M
Headquarters
New York City, New York
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Flexible Work Hours
Remote Work Options
Parental Leave
Despite soaring cybersecurity spending, security teams face mounting challenges. Analysts are overwhelmed with alerts as they attempt to interpret,
Red Cell appoints Ferris as president of healthcare practice.
Timothy G. Ferris, MD, MPH, former NHS England and Mass General executive, joins Red Cell Partners to lead Healthcare Practice.
Valinor, developer of a go-to-market engine designed for technologists building products for defense, raised seed funding from General Catalyst, Founders Fund and Red Cell Partners.
Today, DEFCON AI announced it has secured $44 million in Seed funding, led by Bessemer Venture Partners, with participation from Fifth Growth Fund, Red Cell Partners, and others.